Sol Atriyal Apendiks Görüntülemesinde Ekokardiyografi

Özet

Referanslar

Naccarelli GV, Varker H, Lin J, Schulman KL. Increasing prevalence of atrial fibrillation and flutter in the United States. The American journal of cardiology. 2009;104(11):1534-9.

Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. The Annals of thoracic surgery. 1996;61(2):755-9.

Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Annals of internal medicine. 1999;131(7):492-501.

Rasekh A. Cardiac Arrhythmias: Anticoagulants and Atrial Fibrillation. Texas Heart Institute Journal. 2005;32(2):218.

Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. New England journal of medicine. 2009;361(12):1139-51.

Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, et al. Apixaban versus warfarin in patients with atrial fibrillation. New England Journal of Medicine. 2011;365(11):981-92.

Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. New England Journal of Medicine. 2011;365(10):883-91.

Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, et al. Edoxaban versus Warfarin in Patients with Atrial Fibrillation. New England Journal of Medicine. 2013;369(22):2093-104.

Hughes M, Lip GYH, primary obotGDGftNncgfmoafi, care s. Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review. QJM: An International Journal of Medicine. 2007;100(10):599-607.

Johnson WD, Ganjoo AK, Stone CD, Srivyas RC, Howard M. The left atrial appendage: our most lethal human attachment! Surgical implications✩. European Journal of Cardio-Thoracic Surgery. 2000;17(6):718-22.

Healey JS, Crystal E, Lamy A, Teoh K, Semelhago L, Hohnloser SH, et al. Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. American heart journal. 2005;150(2):288-93.

Emmert MY, Puippe G, Baumüller S, Alkadhi H, Landmesser U, Plass A, et al. Safe, effective and durable epicardial left atrial appendage clip occlusion in patients with atrial fibrillation undergoing cardiac surgery: first long-term results from a prospective device trial. European Journal of Cardio-Thoracic Surgery. 2013;45(1):126-31.

Wunderlich NC, Beigel R, Swaans MJ, Ho SY, Siegel RJ. Percutaneous interventions for left atrial appendage exclusion: options, assessment, and imaging using 2D and 3D echocardiography. JACC: Cardiovascular Imaging. 2015;8(4):472-88.

Ramchand J, Harb SC, Miyasaka R, Kanj M, Saliba W, Jaber WA. Imaging for percutaneous left atrial appendage closure: a contemporary review. Structural Heart. 2019;3(5):364-82.

Su P, Mccarthy KP, Ho SY. Occluding the left atrial appendage: anatomical considerations. Heart. 2008;94(9):1166-70.

Aryana A, Singh SK, Singh SM, O’Neill PG, Bowers MR, Allen SL, et al. Association between incomplete surgical ligation of left atrial appendage and stroke and systemic embolization. Heart Rhythm. 2015;12(7):1431-7.

Di Biase L, Santangeli P, Anselmino M, Mohanty P, Salvetti I, Gili S, et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. Journal of the American College of Cardiology. 2012;60(6):531-8.

Pollick C, Taylor D. Assessment of left atrial appendage function by transesophageal echocardiography. Implications for the development of thrombus. Circulation. 1991;84(1):223-31.

Nucifora G, Faletra FF, Regoli F, Pasotti E, Pedrazzini G, Moccetti T, et al. Evaluation of the left atrial appendage with real-time 3-dimensional transesophageal echocardiography: implications for catheter-based left atrial appendage closure. Circulation: Cardiovascular Imaging. 2011;4(5):514-23.

Vigna C, Russo A, De Rito V, Perna G, Villella A, Testa M, et al. Frequency of left atrial thrombi by transesophageal echocardiography in idiopathic and in ischemic dilated cardiomyopathy. The American journal of cardiology. 1992;70(18):1500-1.

Stoddard MF, Dawkins PR, Prince CR, Ammash NM. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: A transesophageal echocardiographics tudy. Journal of the American College of Cardiology. 1995;25(2):452-9.

Scherr D, Dalal D, Chilukuri K, Dong J, Spragg D, Henrikson CA, et al. Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation. Journal of cardiovascular electrophysiology. 2009;20(4):379-84.

Acar J, Cormier B, Grimberg D, Kawthekar G, Iung B, Scheuer B, et al. Diagnosis of left atrial thrombi in mitral stenosis—usefulness of ultrasound techniques compared with other methods. European heart journal. 1991;12(suppl_B):70-6.

Manning WJ, Weintraub RM, Waksmonski CA, Haering JM, Rooney PS, Maslow AD, et al. Accuracy of transesophageal echocardiography for identifying left atrial thrombi: a prospective, intraoperative study. Annals of internal medicine. 1995;123(11):817-22.

Yao S-S, Ilercil A, Meisner JS, Strom JA, Shirani J. Improved Doppler echocardiographic assessment of the left atrial appendage by peripheral vein injection of sonicated albumin microbubbles. American heart journal. 1997;133(4):400-5.

von der Recke G, Schmidt H, Illien S, Lüderitz B, Omran H. Use of transesophageal contrast echocardiography for excluding left atrial appendage thrombi in patients with atrial fibrillation before cardioversion. Journal of the American Society of Echocardiography. 2002;15(10):1256-61.

Beigel R, Wunderlich NC, Ho SY, Arsanjani R, Siegel RJ. The left atrial appendage: anatomy, function, and noninvasive evaluation. JACC: Cardiovascular imaging. 2014;7(12):1251-65.

Karakus G, Kodali V, Inamdar V, Nanda NC, Suwanjutah T, Pothineni KR. Comparative assessment of left atrial appendage by transesophageal and combined two‐and three‐dimensional transthoracic echocardiography. Echocardiography. 2008;25(8):918-24.

Nakajima H, Seo Y, Ishizu T, Yamamoto M, Machino T, Harimura Y, et al. Analysis of the left atrial appendage by three-dimensional transesophageal echocardiography. The American journal of cardiology. 2010;106(6):885-92.

Marek D, Vindis D, Kocianova E. Real time 3-dimensional transesophageal echocardiography is more specific than 2-dimensional TEE in the assessment of left atrial appendage thrombosis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013;157(1):22-6.

Anwar AM, Nosir YF, Ajam A, Chamsi-Pasha H. Central role of real-time three-dimensional echocardiography in the assessment of intracardiac thrombi. The international journal of cardiovascular imaging. 2010;26:519-26.

Müller S, Feuchtner G, Bonatti J, Müller L, Laufer G, Hiemetzberger R, et al. Value of transesophageal 3D echocardiography as an adjunct to conventional 2D imaging in preoperative evaluation of cardiac masses. Echocardiography. 2008;25(6):624-31.

Agoston I, Xie T, Tiller FL, Rahman AM, Ahmad M. Assessment of left atrial appendage by live three‐dimensional echocardiography: Early experience and comparison with transesophageal echocardiography. Echocardiography: A Journal of Cardiovascular Ultrasound and Allied Techniques. 2006;23(2):127-32.

Agmon Y, Khandheria BK, Gentile F, Seward JB. Echocardiographic assessment of the left atrial appendage. Journal of the American College of Cardiology. 1999;34(7):1867-77.

García-Fernández MA, Torrecilla EG, San Román D, Azevedo J, Bueno H, Moreno MM, et al. Left atrial appendage Doppler flow patterns: implications on thrombus formation. American heart journal. 1992;124(4):955-61.

Kortz M. Delemarre B], van Dantzig JM, Bot H, Kamp O, Visser CA: Left atrial appendage blood flow determined by transesophageal ecliocardiography in healthy subjects. The American journal of cardiology. 1993;71:976-81.

Mügge A, Kühn H, Nikutta P, Grote J, Lopez JAG, Daniel WG. Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: identification of a subgroup of patients at increased embolic risk. Journal of the American College of Cardiology. 1994;23(3):599-607.

Tabata T, Oki T, Fukuda N, Iuchi A, Manabe K, Kageji Y, et al. Influence of aging on left atrial appendage flow velocity patterns in normal subjects. Journal of the American Society of Echocardiography. 1996;9(3):274-80.

Li Y-H, Lai L-P, Shyu K-G, Hwang J-J, Ma H-M, Ko Y-L, et al. Clinical implications of left atrial appendage function: its influence on thrombus formation. International journal of cardiology. 1994;43(1):61-6.

Noda T, Arakawa M, Mrwa H, Ito Y, Kagawa K, Nishigaki K, et al. Effects of heart rate on flow velocity of the left atrial appendage in patients with nonvalvular atrial fibrillation. Clinical cardiology. 1996;19(4):295-300.

Santiago D, Warshofsky M, Mandri GL, Di Tullio M, Coromilas J, Reiffel J, et al. Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: a transesophageal echocardiographic study. Journal of the American College of Cardiology. 1994;24(1):159-64.

Kato H, Yoshida M, Takata K, Kanehara H, Maekawa N, Ohnishi T, et al. Hemodynamic abnormalities in the left atrial appendage in patients with paroxysmal atrial fibrillation, with special reference to albumin-contrast echocardiographic aspects. Cardiology. 2000;92(2):135-43.

Goldman ME, Pearce LA, Hart RG, Zabalgoitia M, Asinger RW, Safford R, et al. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). Journal of the American Society of Echocardiography. 1999;12(12):1080-7.

Handke M, Harloff A, Hetzel A, Olschewski M, Bode C, Geibel A. Left atrial appendage flow velocity as a quantitative surrogate parameter for thromboembolic risk: determinants and relationship to spontaneous echocontrast and thrombus formation–a transesophageal echocardiographic study in 500 patients with cerebral ischemia. Journal of the American Society of Echocardiography. 2005;18(12):1366-72.

Fatkin D, Kelly RP, Feneley MP. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. Journal of the American College of Cardiology. 1994;23(4):961-9.

Li Y-H, Lai L-P, Shyu K-G, Hwang J-J, Kuan P, Lien W-P. Clinical implications of left atrial appendage flow patterns in nonrheumatic atrial fibrillation. Chest. 1994;105(3):748-52.

Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. European Heart Journal. 2020;42(5):373-498.

Bhattal GK, Wang Z, Al-Azizi K, editors. Dobutamine-supported WATCHMAN FLX implant in a patient with recurrent left atrial appendage thrombus and spontaneous echo contrast formation. Baylor University Medical Center Proceedings; 2022: Taylor & Francis.

Sekihara T, Sonoura T, Nakamura Y, Sunayama I, Morishita Y, Ishimi M, et al. Disappearance of an anticoagulation–resistant left atrial appendage thrombus after administration of low–dose pimobendan. Journal of Cardiology Cases. 2020;21(4):157-60.

Vainrib AF, Harb SC, Jaber W, Benenstein RJ, Aizer A, Chinitz LA, et al. Left atrial appendage occlusion/exclusion: procedural image guidance with transesophageal echocardiography. Journal of the American Society of Echocardiography. 2018;31(4):454-74.

Holmes DR, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. Journal of the American College of Cardiology. 2014;64(1):1-12.

Park JW, Bethencourt A, Sievert H, Santoro G, Meier B, Walsh K, et al. Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. Catheterization and Cardiovascular Interventions. 2011;77(5):700-6.

Lam YY, Yip GW, Yu CM, Chan WW, Cheng BC, Yan BP, et al. Left atrial appendage closure with Amplatzer cardiac plug for stroke prevention in atrial fibrillation: Initial Asia‐Pacific experience. Catheterization and Cardiovascular Interventions. 2012;79(5):794-800.

Sayfalar

17-32

Gelecek

17 Şubat 2026

Lisans

Lisans